USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/16040
Title: Diagnostic markers of urinary bladder tumors
Authors: Vladanov, Ivan
Pleșacov, Alexei
Colta, Artur
Ghicavii, Vitalii
Keywords: bladder tumors;tumor markers
Issue Date: 2021
Publisher: The Scientific Medical Association of the Republic of Moldova
Citation: VLADANOV, Ivan, PLESACOV, Alexei, COLTA, Artur, GHICAVII, Vitalii. Diagnostic markers of urinary bladder tumors. In: The Moldovan Medical Journal. 2021, vol. 64, no 1, pp. 71-75. ISSN 2537-6381. DOI: 10.5281/zenodo.4527239
Abstract: Abstract. Background: The perfect method for laboratory diagnosis of bladder cancer should have high sensitivity and specificity, should be easily reproducible, inexpensive, be suitable for primary diagnosis, screening, and follow-up of patients, for timely detection of recurrence. In clinical practice, for bladder cancer diagnostics have been used the following markers: UBC, BTA, “ImmunoCyt”, NMP22, “UroVision», and others. Each method has relative advantages and disadvantages. The study has demonstrated an influence on the test result of the histological structure and grade of the tumor, presence of hematuria, urolithiasis, chronic inflammatory malignancies, recent surgical procedures on the urinary tract. Apparently, the use of a palette of markers in connection with imaging techniques will increase the diagnostic capabilities, but it is still not clear which elements should be present in such a palette. Conclusions: At present, basic diagnostic methods for bladder cancer remain: USG, MRI, CT, and endoscopic methods. The laboratory methods that exist are not informative enough. Each marker has serious restrictions, but possibly the complex application will allow increasing the diagnostic value in the future, therefore it is necessary to develop new markers of bladder cancer or to study the results of the complex application of several known markers to increase the value of the laboratory diagnosis of primary bladder cancer and recurrent.
metadata.dc.relation.ispartof: The Moldovan Medical Journal
URI: http://moldmedjournal.md/wp-content/uploads/2021/03/64-1-0-MMJ-vers-3-martie.pdf
http://repository.usmf.md/handle/20.500.12710/16040
ISSN: 2537-6381
2537-6373
Appears in Collections:The Moldovan Medical Journal, Vol. 64, No 1, March 2021

Files in This Item:
File Description SizeFormat 
Vladanov_Plesacov_Diagnostic_markers_of_urinary_bladder_tumors_p.71_75.pdf161.89 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback